Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have moderate to severe psoriasis, meaning that before starting their current treatment, more than 10% of their body surface was affected, or their psoriasis severity score (PASI) was above 10
- People who already have dermatology (skin specialist) appointments planned over roughly 24 months, as no extra study visits are required
- People who are willing to sign a consent form agreeing to take part in the study
Who may not be able to join:
- People who have a seriously weakened immune system for reasons unrelated to their psoriasis or its treatment — for example, those taking strong immune-suppressing medications for another condition, those with uncontrolled HIV infection, or those with another condition that significantly weakens the immune system
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jonathan Krygier, MD, CHU SAINT-PIERRE BRUXELLES
Phone: 025358385
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of anogenital warts
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.